Cargando…
Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664879/ https://www.ncbi.nlm.nih.gov/pubmed/29022567 http://dx.doi.org/10.4103/jpgm.JPGM_443_17 |
| _version_ | 1783275082472226816 |
|---|---|
| author | Dutta, D Kalra, S Sharma, M |
| author_facet | Dutta, D Kalra, S Sharma, M |
| author_sort | Dutta, D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5664879 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56648792017-12-26 Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” Dutta, D Kalra, S Sharma, M J Postgrad Med Letters Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5664879/ /pubmed/29022567 http://dx.doi.org/10.4103/jpgm.JPGM_443_17 Text en Copyright: © 2017 Journal of Postgraduate Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letters Dutta, D Kalra, S Sharma, M Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title | Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title_full | Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title_fullStr | Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title_full_unstemmed | Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title_short | Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| title_sort | reply to letter to editor regarding the article, “adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy” |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664879/ https://www.ncbi.nlm.nih.gov/pubmed/29022567 http://dx.doi.org/10.4103/jpgm.JPGM_443_17 |
| work_keys_str_mv | AT duttad replytolettertoeditorregardingthearticleadenosinemonophosphateactivatedproteinkinasebasedclassificationofdiabetespharmacotherapy AT kalras replytolettertoeditorregardingthearticleadenosinemonophosphateactivatedproteinkinasebasedclassificationofdiabetespharmacotherapy AT sharmam replytolettertoeditorregardingthearticleadenosinemonophosphateactivatedproteinkinasebasedclassificationofdiabetespharmacotherapy |